987 related articles for article (PubMed ID: 31182921)
1. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy.
Yang F; Qin Y; Wang Y; Meng S; Xian H; Che H; Lv J; Li Y; Yu Y; Bai Y; Wang L
Int J Biol Sci; 2019; 15(5):1010-1019. PubMed ID: 31182921
[TBL] [Abstract][Full Text] [Related]
2. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.
Chen H; Tran D; Yang HC; Nylander S; Birnbaum Y; Ye Y
Cardiovasc Drugs Ther; 2020 Aug; 34(4):443-461. PubMed ID: 32335797
[TBL] [Abstract][Full Text] [Related]
3. Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway.
Cui L; Li C; Zhuo Y; Yang L; Cui N; Li Y; Zhang S
Biomed Pharmacother; 2020 Aug; 128():110216. PubMed ID: 32497863
[TBL] [Abstract][Full Text] [Related]
4. Berberine inhibits NLRP3 inflammasome activation by regulating mTOR/mtROS axis to alleviate diabetic cardiomyopathy.
Zhong C; Xie Y; Wang H; Chen W; Yang Z; Zhang L; Deng Q; Cheng T; Li M; Ju J; Liu Y; Liang H
Eur J Pharmacol; 2024 Feb; 964():176253. PubMed ID: 38096968
[TBL] [Abstract][Full Text] [Related]
5. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction.
Wang Q; Wei S; Zhou S; Qiu J; Shi C; Liu R; Zhou H; Lu L
Immunol Cell Biol; 2020 Jan; 98(1):54-66. PubMed ID: 31625631
[TBL] [Abstract][Full Text] [Related]
7. Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction.
Qiu WQ; Pan R; Tang Y; Zhou XG; Wu JM; Yu L; Law BY; Ai W; Yu CL; Qin DL; Wu AG
Biomed Pharmacother; 2020 Oct; 130():110575. PubMed ID: 32768883
[TBL] [Abstract][Full Text] [Related]
8. Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A.
Zhang L; Lu L; Zhong X; Yue Y; Hong Y; Li Y; Li Y
Eur J Pharmacol; 2019 Jun; 852():99-106. PubMed ID: 30851273
[TBL] [Abstract][Full Text] [Related]
9. AMPK as a potential pharmacological target for alleviating LPS-induced acute lung injury partly via NLRC4 inflammasome pathway inhibition.
He Y; Xu K; Wang Y; Chao X; Xu B; Wu J; Shen J; Ren W; Hu Y
Exp Gerontol; 2019 Oct; 125():110661. PubMed ID: 31319131
[TBL] [Abstract][Full Text] [Related]
10. Lychee seed polyphenol protects the blood-brain barrier through inhibiting Aβ(25-35)-induced NLRP3 inflammasome activation via the AMPK/mTOR/ULK1-mediated autophagy in bEnd.3 cells and APP/PS1 mice.
Xiong R; Zhou XG; Tang Y; Wu JM; Sun YS; Teng JF; Pan R; Law BY; Zhao Y; Qiu WQ; Wang XL; Liu S; Wang YL; Yu L; Yu CL; Mei QB; Qin DL; Wu AG
Phytother Res; 2021 Feb; 35(2):954-973. PubMed ID: 32893437
[TBL] [Abstract][Full Text] [Related]
11. Pien-Tze-Huang, a Chinese patent formula, attenuates NLRP3 inflammasome-related neuroinflammation by enhancing autophagy via the AMPK/mTOR/ULK1 signaling pathway.
Huang Z; Zhou X; Zhang X; Huang L; Sun Y; Cheng Z; Xu W; Li CG; Zheng Y; Huang M
Biomed Pharmacother; 2021 Sep; 141():111814. PubMed ID: 34146853
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.
Kim SH; Kim G; Han DH; Lee M; Kim I; Kim B; Kim KH; Song YM; Yoo JE; Wang HJ; Bae SH; Lee YH; Lee BW; Kang ES; Cha BS; Lee MS
Autophagy; 2017 Oct; 13(10):1767-1781. PubMed ID: 28933629
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GAS5 inhibits NLRP3 inflammasome activation-mediated pyroptosis in diabetic cardiomyopathy by targeting miR-34b-3p/AHR.
Xu Y; Fang H; Xu Q; Xu C; Yang L; Huang C
Cell Cycle; 2020 Nov; 19(22):3054-3065. PubMed ID: 33092444
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-223 attenuates the NLRP3 inflammasome activation, fibrosis, and apoptosis in diabetic cardiomyopathy.
Xu D; Zhang X; Chen X; Yang S; Chen H
Life Sci; 2020 Sep; 256():117980. PubMed ID: 32561396
[TBL] [Abstract][Full Text] [Related]
16. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE
Tang G; Duan F; Li W; Wang Y; Zeng C; Hu J; Li H; Zhang X; Chen Y; Tan H
Biomed Pharmacother; 2019 Nov; 119():109410. PubMed ID: 31518877
[TBL] [Abstract][Full Text] [Related]
17. Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages.
Ke P; Shao BZ; Xu ZQ; Wei W; Han BZ; Chen XW; Su DF; Liu C
PLoS One; 2016; 11(9):e0155076. PubMed ID: 27611972
[TBL] [Abstract][Full Text] [Related]
18. SP1-induced ZFAS1 aggravates sepsis-induced cardiac dysfunction via miR-590-3p/NLRP3-mediated autophagy and pyroptosis.
Liu JJ; Li Y; Yang MS; Chen R; Cen CQ
Arch Biochem Biophys; 2020 Nov; 695():108611. PubMed ID: 33002446
[TBL] [Abstract][Full Text] [Related]
19. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome.
Peng X; Yang T; Liu G; Liu H; Peng Y; He L
Int Immunopharmacol; 2018 Dec; 65():448-457. PubMed ID: 30388519
[TBL] [Abstract][Full Text] [Related]
20. Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.
Zhang X; Wang Z; Li X; Chen J; Yu Z; Li X; Sun C; Hu L; Wu M; Liu L
J Ethnopharmacol; 2023 Jun; 309():116304. PubMed ID: 36870461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
